Spectra Optia(®) for Automated Red Blood Cell Exchange in Patients with Sickle Cell Disease: A NICE Medical Technology Guidance

The Spectra Optia(®) automated apheresis system, indicated for red blood cell exchange in people with sickle cell disease, underwent evaluation by the National Institute for Health and Care Excellence, which uses its Medical Technologies Advisory Committee to make recommendations. The company (Terum...

Descripción completa

Detalles Bibliográficos
Autores principales: Willits, Iain, Cole, Helen, Jones, Roseanne, Carter, Kimberley, Arber, Mick, Jenks, Michelle, Craig, Joyce, Sims, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506506/
https://www.ncbi.nlm.nih.gov/pubmed/28110486
http://dx.doi.org/10.1007/s40258-016-0302-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506506/
https://www.ncbi.nlm.nih.gov/pubmed/28110486
http://dx.doi.org/10.1007/s40258-016-0302-x

Ejemplares similares